Open AccessExpression and Clinical Value of Eukaryotic Translation Elongation Factor 1A1 (EEF1A1) in Diffuse Large B Cell Lymphoma
Author(s) -
Tiejun Gong,
Yue-Rong Shuang
Publication year - 2021
Publication title -
international journal of general medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.722
H-Index - 36
ISSN - 1178-7074
DOI - 10.2147/ijgm.s324645
Subject(s) - eukaryotic translation elongation factor 1 alpha 1 , medicine , proportional hazards model , immunohistochemistry , lymphoma , malignancy , pathology , oncology , cancer research , biology , gene , ribosome , rna , biochemistry
The eukaryotic translation elongation factor 1A1 (EEF1A1) participates in protein translation and has been reported to be involved in tumor progression such as hepatocellular carcinoma. Diffuse large B-cell lymphoma (DLBCL) is the most common lymphoid malignancy in adults. In the present study, we aimed to detect the expression of EEF1A1 in DLBCL and to analyze its relationship with prognosis.